Advocacy

September 20, 2024

2025 Medicare Changes & What They Mean For You

After viewing this webinar please provide your feedback by taking our short questionnaire to let us know what you think about the presentation and content. We’d love to hear from you!

In 2022 the Inflation Reduction Act was passed which put in place new protections for Medicare beneficiaries. These changes in 2024 and 2025 affect Medicare benefits and potential coverage of your psoriasis and psoriatic arthritis medication(s). View this pre-recorded webinar with Medicare and Insurance Advisor Jason Mackey from Medicare Blueprint Advisors, LLC, and moderator Jason Harris, NPF Vice President of Government Relations and Advocacy, to learn more about:

  • The cap on out-of-pocket expenses for Part D enrollees – when it applies and when it doesn’t.
  • Elimination of the “donut hole” and use of a three-phase benefit plan.
  • “Smoothing” and what that means for you.
  • Changes for premiums.

Hear what you need to know before open enrollment begins October 15, 2024.

More on the upcoming Medicare changes:

  • Psound Bytes™ Podcast, Let’s Talk 2025 Medicare Changes: Hear dermatologist and rheumatologist Dr. Alice Gottlieb, Medical Director, Mount Sinai Beth Israel Dermatology, Kimberly and Eric J. Waldman Department of Dermatology at The Icahn School of Medicine at Mount Sinai, New York, address Medicare and upcoming changes from her perspective as a physician.
  • Join us in November 2024 for a Town Hall discussion with several panelists addressing your questions about Medicare. Look for upcoming announcements in NPF Advance Weekly or sign up for advance notifications at psoriasis.org/subscribe.

Presenting Sponsor

Sun Pharma Logo

Gold Level

Share
Related Items

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorCommunity Health Charities logo

Copyright © 1996-2024 National Psoriasis Foundation/USA


Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.